Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.

MLA

Bartholomew, Tyler S., et al. “Project CHARIOT: Study Protocol for a Hybrid Type 1 Effectiveness-Implementation Study of Comprehensive Tele-Harm Reduction for Engagement of People Who Inject Drugs in HIV Prevention Services.” Addiction Science & Clinical Practice, vol. 19, no. 1, Mar. 2024, pp. 1–21. EBSCOhost, https://doi.org/10.1186/s13722-024-00447-9.

APA

Bartholomew, T. S., Plesons, M., Serota, D. P., Alonso, E., Metsch, L. R., Feaster, D. J., Ucha, J., Suarez Jr., E., Forrest, D. W., Chueng, T. A., Ciraldo, K., Brooks, J., Smith, J. D., Barocas, J. A., & Tookes, H. E. (2024). Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Addiction Science & Clinical Practice, 19(1), 1–21. https://doi.org/10.1186/s13722-024-00447-9

Chicago

Bartholomew, Tyler S., Marina Plesons, David P. Serota, Elizabeth Alonso, Lisa R. Metsch, Daniel J. Feaster, Jessica Ucha, et al. 2024. “Project CHARIOT: Study Protocol for a Hybrid Type 1 Effectiveness-Implementation Study of Comprehensive Tele-Harm Reduction for Engagement of People Who Inject Drugs in HIV Prevention Services.” Addiction Science & Clinical Practice 19 (1): 1–21. doi:10.1186/s13722-024-00447-9.